The Food and Drug Administration has granted Fast Track designation to AMX0114 for the treatment of amyotrophic lateral sclerosis (ALS).

Living close to cyanobacterial harmful algal blooms in US water bodies is associated with increased risk of mortality from ALS.

Thomas Mulligan explains how a brain implant enables ALS patients to control digital devices. Canada rescinds Digital Services Tax after Trump cuts off U.S. trade talks ...

A new clinic at Vanderbilt University Medical Center is a ray of light for patients like Louis Del Ray, who was diagnosed ...

Columnist Juliet Taylor used to face difficulties with stoicism, but her late husband's ALS diagnosis forced to her feel her ...

Diagnosed with ALS at 33, Brooke Eby launched ALStogether, an online community offering connection, advice, and resources.

Osteoarthritis drug developer Paradigm says its purchase of an oral drug candidate won't distract it from its key phase III .